QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=7F854CC951E33A2E03211A8E9C96824D;jsessionid=10327DDCC9C29F954F3A41ADB563361C;jsessionid=9751C6450C438058F8AFB2CDFD1038E8;jsessionid=C8FFB4B4D654D33E32374A291B35D3A6;jsessionid=87FC38769DA4895A4FFDF0411CBAE6F8 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=7F854CC951E33A2E03211A8E9C96824D;jsessionid=10327DDCC9C29F954F3A41ADB563361C;jsessionid=9751C6450C438058F8AFB2CDFD1038E8;jsessionid=C8FFB4B4D654D33E32374A291B35D3A6;jsessionid=87FC38769DA4895A4FFDF0411CBAE6F8